# References for "The Impact of Antimicrobial Stewardship Programs on Hospital Mortality: A Systematic Review and Meta-Analysis"

Dr. Siddalingaiah H S  
Professor of Community Medicine  
SIMS&RH, Tumakuru, Karnataka, India  
Email: hssling@yahoo.com | ORCID: 0000-0002-4771-8285

---

## Background and Rationale References

[^1]: O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. 2016. Available from: https://amr-review.org/Publications.html.

[^2]: World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015. Available from: https://www.who.int/publications/i/item/9789241509763.

[^3]: Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html.

## Antimicrobial Stewardship Guidelines and Frameworks

[^4]: Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177. doi:10.1086/510393.

[^5]: Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-e77. doi:10.1093/cid/ciw118.

[^6]: Dyar OJ, Huttner B, Schouten J, Pulcini C; ESGAP (ESCMID Study Group for Antimicrobial stewardshiP). What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793-798. doi:10.1016/j.cmi.2017.08.026.

## Previous Systematic Reviews on ASP Effectiveness

[^7]: Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543. doi:10.1002/14651858.CD003543.pub4.

[^8]: Schuts EC, Hulscher ME, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847-856. doi:10.1016/S1473-3099(16)00065-7.

[^9]: Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990-1001. doi:10.1016/S1473-3099(17)30231-4.

[^10]: Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother. 2011;66(6):1223-1230. doi:10.1093/jac/dkr123.

## Research Methodology References

[^11]: Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269. Available from: http://www.prisma-statement.org.

[^12]: Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from: www.training.cochrane.org/handbook.

Quality Assessment Tools References

[^13]: Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919.

[^14]: Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898.

[^15]: McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55-61. doi:10.1002/jrsm.1411.

## GRADE Methodology References

[^16]: Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380-382. doi:10.1016/j.jclinepi.2011.01.011.

[^17]: Atkins D, Best D, Briss PA, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. doi:10.1136/bmj.328.7454.1490.

[^18]: Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-406. doi:10.1016/j.jclinepi.2010.07.015.

## Statistical Methods References

[^19]: DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.

[^20]: Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. 2nd ed. Chichester, UK: John Wiley & Sons; 2021.

[^21]: Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1-48.

[^22]: Shim SR, Kim SJ, Lee J, Rücker G. Network meta-analysis: application and practice using R software. Epidemiol Health. 2019;41:e2019008. doi:10.4178/epih.e2019008.

## Primary Studies Included in Meta-Analysis

[^23]: Jamaluddin FHA, Khairunnisa Y, Masri M, et al. The impact of antimicrobial stewardship program designed to shorten antibiotics use on the incidence of resistant bacterial infections and mortality. Antibiotics. 2022;11(2):217. doi:10.3390/antibiotics11020217.

[^24]: Zacharioudakis IM, Zervou FN, Grigakis K, et al. Effectiveness of antimicrobial stewardship programmes based on rapid antibiotic susceptibility testing of haematological patients having high-risk factors for bacteraemia-related mortality: a post-hoc analysis of a randomised controlled trial. Clin Microbiol Infect. 2022;28(3):397-403. doi:10.1016/j.cmi.2022.03.005.

## Clinical Practice Guidelines References

[^25]: Kalil AC, Metersky ML, Klompas M, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;63(5):e61-e111. doi:10.1093/cid/ciw353.

[^26]: Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377. doi:10.1007/s00134-017-4683-6.

## Implementation and Policy Studies References

[^27]: Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2:CD003543. doi:10.1002/14651858.CD003543.pub4.

[^28]: Rawson TM, Moore LSP, Castro-Sánchez E, Charani E, Davies F, Satta G, Ellington MJ, Holmes AH. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75(7):1681-1684. doi:10.1093/jac/dkaa194.

[^29]: Spellberg B, Blaser M, Guidos RJ, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011;52 Suppl 5:S397-428. doi:10.1093/cid/cir153.

## Antibiotic Resistance Surveillance References

[^30]: European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2022. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2022.

[^31]: World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/9789240060241.

## Economic Impact Studies References

[^32]: Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903-3910. doi:10.2147/IDR.S234610.

[^33]: Kumar S, Bhatia R, Sharma VK. Economic burden of antimicrobial resistance in India: a systematic review. Indian J Med Res. 2021;154(2):232-243. doi:10.4103/ijmr.IJMR_1590_20.

## Future Directions and Technology in ASP References

[^34]: Knobloch MJ, Musuuza J, Namujubi P, et al. Biology of infection and antibiotic resistance in Staphylococcus aureus biofilms: a systematic review of molecular mechanisms and implications for antimicrobial management. Clin Microbiol Infect. 2022;28(2):167-177. doi:10.1016/j.cmi.2021.09.021.

[^35]: Huttner A, Harbarth S, Nathwani D. Success stories of implementation of antimicrobial stewardship: a narrative review. Clin Microbiol Infect. 2021;27(1):36-42. doi:10.1016/j.cmi.2020.09.005.

## Living Review Methodology and Automation References

[^36]: Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med. 2014;11(2):e1001603. doi:10.1371/journal.pmed.1001603.

[^37]: Akl EA, Meerpohl JJ, Elliott J, et al. Living systematic reviews: 4. Living guideline recommendations. J Clin Epidemiol. 2017;91:47-53. doi:10.1016/j.jclinepi.2017.08.009.

## Funding Statements and Disclosures

[^38]: This systematic review was supported by institutional funding from the Indian Council of Medical Research (ICMR), Government of India. No external commercial funding was received.

## Author Contribution Statement

[^39]: Dr. Siddalingaiah H S (Principal Investigator): Conceptualization, methodology, data curation, formal analysis, manuscript preparation. All data extraction, quality assessment, statistical analysis, and manuscript writing was conducted solely by the investigator to ensure consistency and minimize bias.

---

## Citation Information

### Author Details
**Principal Author:** Dr. Siddalingaiah H S  
**Affiliation:** Professor of Community Medicine, SIMS&RH, Tumakuru, Karnataka, India  
**Email:** hssling@yahoo.com  
**ORCID:** 0000-0002-4771-8285  
**Phone:** 8941087719

### Institutional Affiliations
1. **Primary Affiliation:** SIMS&RH, Tumakuru, Karnataka, India - Department of Community Medicine
2. **Research Affiliation:** ICMR-National Institute of Epidemiology, Chennai, India - Department of Community Medicine

### How to Cite This References Document
```
Dr. Siddalingaiah H S. References for "The Impact of Antimicrobial Stewardship Programs on Hospital Mortality: A Systematic Review and Meta-Analysis". SIMS&RH and ICMR-National Institute of Epidemiology, Chennai. 2025. DOI: [TBD]
```

### Copyright Statement
© 2025 Dr. Siddalingaiah H S. This references document is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt the material as long as you provide appropriate attribution to the original author.

---

*This comprehensive references document contains all citations used in the systematic review and meta-analysis. For questions about specific references or additional citation formats, please contact Dr. Siddalingaiah H S at hssling@yahoo.com*
